Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) has disclosed details regarding filing a registration statement linked to the proposed merger with Quoin Pharmaceuticals. Cellect Biotechnology has achieved a lot over the years by turning to its innovative technology. One of the areas it continues to witness massive success is stem cell […]